Allurion Technologies (ALURW) Equity Average (2022 - 2026)
Allurion Technologies (ALURW) reported Equity Average of -$77.5 million for Q1 2026, down 4.96% on a YoY basis from -$81.6 million in Q1 2025, and up 3.13% quarter-over-quarter from -$80.1 million in Q4 2025.
Allurion Technologies (ALURW) Equity Average (2022 - 2026) Analysis & Trends
Allurion Technologies has reported Equity Average for 5 years, with the latest figure at -$77.5 million in Q1 2026.
- For the quarter ending Q1 2026, Equity Average fell 4.96% year-over-year to -$77.5 million; the trailing twelve-month figure through Mar 2026 stood at -$77.5 million (down 4.96% YoY), and the FY2025 full-year result was -$77.6 million, down 3.95% from the prior year.
- Equity Average for Q1 2026 stood at -$77.5 million, up from -$80.1 million in the prior quarter.
- The five-year high for Equity Average was -$13.4 million in Q3 2022, with the low at -$80.1 million in Q4 2025.
- Historically, Equity Average has averaged -$60.9 million across 5 years, with a median of -$67.7 million in 2024.
- Annual changes were most pronounced in 2023 — Equity Average plunged 361.23% — and 2025, when it rose 2.18%.
- Allurion Technologies' Equity Average stood at -$26.2 million in 2022, then slumped by 136.35% to -$62.0 million in 2023, then fell by 15.09% to -$71.4 million in 2024, then decreased by 12.15% to -$80.1 million in 2025, then gained by 3.13% to -$77.5 million in 2026.
- The last three Equity Average figures came in at -$77.5 million (Q1 2026), -$80.1 million (Q4 2025), and -$73.5 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 52.42 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 22.70 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 49.03 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 25.17 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 10.33 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 13.05 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 2.85 Bn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 10.53 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 7.18 Bn |
| 10 | Allurion Technologies | - | - | 1.23 Mn | -77.55 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -77.55 Mn |
| Dec 31, 2025 | -80.06 Mn |
| Sep 30, 2025 | -73.45 Mn |
| Jun 30, 2025 | -66.88 Mn |
| Mar 31, 2025 | -73.88 Mn |
| Dec 31, 2024 | -71.38 Mn |
| Sep 30, 2024 | -67.69 Mn |
| Jun 30, 2024 | -68.37 Mn |
| Mar 31, 2024 | -68.73 Mn |
| Dec 31, 2023 | -62.03 Mn |
| Sep 30, 2023 | -61.99 Mn |
| Jun 30, 2023 | -60.44 Mn |
| Mar 31, 2023 | -40.99 Mn |
| Dec 31, 2022 | -26.24 Mn |
| Sep 30, 2022 | -13.44 Mn |